Physician profile
Michael D Patterson
NPI 1437341633
$5,766.16
in general payments reported to CMS, 2019-2025
10 companies · $1,313 in 2025
The $1,313 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $124 · 2021: $403 · 2022: $1,351 · 2023: $971 · 2024: $804 · 2025: $1,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,087.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,464.88 | 2019-2025 | Proclaim, Eterna, Penta |
| Si-Bone, INC. | $473.75 | 2019-2022 | |
| Mml US, INC. | $209.56 | 2023 | Reactiv8 |
| Vertos Medical, INC. | $165.40 | 2022 | |
| Spr Therapeutics, INC | $161.78 | 2025 | Sprint Pns System |
| Bausch & Lomb Americas INC. | $118.55 | 2023 | |
| Stryker Corporation | $63.00 | 2021-2023 | Serrato |
| Avanos Medical | $55.88 | 2023 | Coolief* Cooled Radiofrequency |
| Johnson & Johnson Surgical Vision, INC. | $33.01 | 2025 | Tecnis Iol |
| Tg Therapeutics, INC. | $20.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.